<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for AMGN</title>
    <link />
    <description>Headlines for Amgen, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Amgen: Financial Analysis And Valuation</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1459031-amgen-financial-analysis-and-valuation.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 24 May 2013 03:26:19 GMT</pubDate>
    </item>
    <item>
      <title>Amgen Stock Checkup for May</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/23/amgen-stock-checkup-for-may/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 23 May 2013 14:00:00 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Raising The Drugs Industry Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11932614/1/5-stocks-raising-the-drugs-industry-higher.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 23 May 2013 13:03:00 GMT</pubDate>
    </item>
    <item>
      <title>A New Cancer-Killing Virus</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/22/a-new-cancer-killing-virus/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 22 May 2013 18:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Can Financial Innovation Unlock a Cure for Cancer?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/22/can-financial-innovation-unlock-a-cure-for-cancer/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 22 May 2013 18:32:00 GMT</pubDate>
    </item>
    <item>
      <title>Stock Market News for May 22, 2013 - Market News</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99854/stock-market-news-for-may-22-2013.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 22 May 2013 14:36:01 GMT</pubDate>
    </item>
    <item>
      <title>1 Biotech, 1 Financial And 1 Consumer Goods Company With Recent Intensive Insider Selling</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1453291-1-biotech-1-financial-and-1-consumer-goods-company-with-recent-intensive-insider-selling.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 22 May 2013 10:46:06 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Goldman Sachs Reiterates Buy Rating, $130 PT on Amgen Ahead of AMG 386 Phase 3 Data</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/05/3611176/update-goldman-sachs-reiterates-buy-rating-130-pt-on-amg.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 22 May 2013 08:29:44 GMT</pubDate>
    </item>
    <item>
      <title>AbbVie Reaches New Highs Thanks To Humira</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1452791-abbvie-reaches-new-highs-thanks-to-humira.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 22 May 2013 07:48:24 GMT</pubDate>
    </item>
    <item>
      <title>Amgen Inc (AMGN): Today's Featured Health Care Winner</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11930342/1/amgen-inc-amgn-todays-featured-health-care-winner.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 21 May 2013 17:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Amgen, Inc. Management Presents at UBS Global Healthcare Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1450581-amgen-inc-management-presents-at-ubs-global-healthcare-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 21 May 2013 13:47:01 GMT</pubDate>
    </item>
    <item>
      <title>Is There a Pill For That? Forest Labs’ Iffy Pipeline</title>
      <link>http://www.fool.com/news/xt/ycharts/ycharts.com/analysis/story/is_there_a_pill_for_that_forest_labs_iffy_pipeline.aspx?source=itxwebtxt0000015</link>
      <author>YCharts</author>
      <pubDate>Tue, 21 May 2013 13:27:09 GMT</pubDate>
    </item>
    <item>
      <title>Today’s 3 Worst Stocks</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/todays-3-worst-stocks-93/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 19:27:00 GMT</pubDate>
    </item>
    <item>
      <title>Market Close Report: NASDAQ Composite index closes at 3,496.43 down -2.54 points</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/market-close-report-nasdaq-composite-index-closes-at-349643-down-254-points-cm247331.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 20 May 2013 16:45:13 GMT</pubDate>
    </item>
    <item>
      <title>Will Amgen's Novel Drug Revolutionize Cancer Treatment?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/will-amgens-novel-drug-revolutionize-cancer-treatm/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 13:42:00 GMT</pubDate>
    </item>
    <item>
      <title>China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart Failure Drug</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1445331-china-biotech-in-review-sciclone-pharma-in-licenses-china-rights-to-heart-failure-drug.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 19 May 2013 09:14:20 GMT</pubDate>
    </item>
    <item>
      <title>Here's Why Amgen Shares Are Worth $117 To $126 Today</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1444941-here-s-why-amgen-shares-are-worth-117-to-126-today.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sat, 18 May 2013 01:03:21 GMT</pubDate>
    </item>
    <item>
      <title>AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11926025/1/agn-lly-biib-celg-and-amgn-pushing-health-care-sector-downward.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 16 May 2013 13:04:00 GMT</pubDate>
    </item>
    <item>
      <title>Best And Worst ETFs, Mutual Funds And Key Holdings: All-Cap Value Style</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1439981-best-and-worst-etfs-mutual-funds-and-key-holdings-all-cap-value-style.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 May 2013 10:04:20 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi and Regeneron's Latest Partnership</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/sanofi-and-regenerons-latest-partnership-4/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 21:13:00 GMT</pubDate>
    </item>
  </channel>
</rss>
